Physician profile
Richard Berg
NPI 1124097977
$2,833.17
in general payments reported to CMS, 2019-2025
11 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $636 · 2021: $859 · 2022: $57.12 · 2023: $460 · 2024: $335 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $959.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,585.31 | 2019-2021 | |
| Davol INC. | $389.50 | 2019-2024 | Phasix Mesh |
| Leica Microsystems INC. | $190.00 | 2023 | |
| Dilon Technologies, INC. | $175.47 | 2023 | Hemoblast Bellows |
| Medtronic, INC. | $124.72 | 2025 | Transorb |
| Avanos Medical | $113.04 | 2024 | On-Q* Pump and Accessories |
| Intuitive Surgical, INC. | $109.45 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $89.84 | 2024 | Myrisk |
| Convatec INC. | $21.36 | 2025 | |
| Integra Lifesciences Corporation | $19.36 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $15.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.